Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support

Higashi, Hideki and Barendregt, Jan (2012) Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support. Addiction, 107 3: 658-670. doi:10.1111/j.1360-0443.2011.03632.x

Author Higashi, Hideki
Barendregt, Jan
Title Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support
Journal name Addiction   Check publisher's open access policy
ISSN 0965-2140
Publication date 2012-03
Year available 2011
Sub-type Article (original research)
DOI 10.1111/j.1360-0443.2011.03632.x
Volume 107
Issue 3
Start page 658
End page 670
Total pages 13
Place of publication Oxford, United Kingdom
Publisher Wiley-Blackwell Publishing
Collection year 2012
Language eng
Formatted abstract
To examine the cost-effectiveness of personal smoking cessation support in Vietnam.

Design, setting and participants:
We followed up the population aged 15 and over in 2006 to model the costs and health gains associated with five interventions: physician brief advice; nicotine replacement therapy (patch and gum); Bupropion; and Varenicline. Threshold analysis was undertaken to determine the price levels of pharmaceuticals for the interventions to be cost-effective. A multi-state life table model was constructed such that the interventions affect the smoking cessation behaviour of the age cohorts, and the resulting smoking prevalence defines their health outcomes. A healthcare perspective was employed.

Cost-effectiveness is measured in 2006 Vietnamese Dong (VND) per disability-adjusted life year (DALY) averted. We adopted the WHO thresholds of being “cost-effective” if less than 3 times GDP per capita (VND 34,600,000) and “very cost-effective” if less than GDP per capita (VND 11,500,000).

The cost-effectiveness result of physician brief advice was VND 1,583,000 per DALY averted (Int. $493), which was “very cost-effective”. Varenicline dominated Bupropion and nicotine-replacement therapies, although it did not fall within the range of being “cost-effective” under different scenarios. The threshold analysis revealed that prices of pharmaceuticals must be substantially lower than the levels from other countries if pharmacological therapies are to be cost-effective in Vietnam.

Physician brief advice is a cost-effective intervention and should be included in the priority list of tobacco control policy in Vietnam. Pharmacological therapies are not cost-effective, and so they are not recommended in Vietnam at this time unless pharmaceuticals would be produced locally at substantially lower costs in the future.
Keyword Tobacco
Smoking cessation
Economic evaluation
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ
Additional Notes Article first published online: 1 November 2011.

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2012 Collection
School of Public Health Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 13 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 14 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 20 Sep 2011, 12:14:32 EST by Mr Hideki Higashi on behalf of School of Public Health